Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Fagan

Showing results (31-40 of 279) with videos related to

Pageof 28
Sort By:
The American Journal of Psychiatry|December 8, 2006
Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementiaJohn G Csernansky, Hongxin Dong, Anne M Fagan, et al.
Journal of Neurochemistry|November 5, 2004
A proteasomal stress response: pre-treatment with proteasome inhibitors increases proteasome activity and reduces neuronal vulnerability to oxidative injuryChul-Sang Lee, Lee Y Tee, Timothy Warmke, et al.
Neuropsychology|November 11, 2009
The utility of intraindividual variability in selective attention tasks as an early marker for Alzheimer's diseaseJanet M Duchek, David A Balota, Chi-Shing Tse, et al.
Annals of Neurology|March 5, 2009
Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderlyAnne M Fagan, Denise Head, Aarti R Shah, et al.
Alzheimer Disease and Associated Disorders|June 11, 2020
Physical Exercise and Longitudinal Trajectories in Alzheimer Disease Biomarkers and Cognitive FunctioningMarta Stojanovic, Yuxuan Jin, Anne M Fagan, et al.
Alzheimer'S Research & Therapy|June 15, 2021
GPS driving: a digital biomarker for preclinical Alzheimer diseaseSayeh Bayat, Ganesh M Babulal, Suzanne E Schindler, et al.
Journal of the International Neuropsychological Society : JINS|September 30, 2015
Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children StudyAndrew J Aschenbrenner, David A Balota, Anne M Fagan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 28, 2018
Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's diseaseCourtney L Sutphen, Lena McCue, Elizabeth M Herries, et al.
Journal of the International Neuropsychological Society : JINS|December 12, 2019
The Relation Between Personality and Biomarkers in Sensitivity and Conversion to Alzheimer-Type DementiaJanet M Duchek, Andrew J Aschenbrenner, Anne M Fagan, et al.
Biological Psychiatry|November 7, 2009
Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's diseaseAnthony L Hinrichs, Mark A Mintun, Denise Head, et al.
Pageof 28

Showing results (31-40 of 279) with videos related to

Sort By:
Pageof 28
The American Journal of Psychiatry|December 8, 2006
Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementiaJohn G Csernansky, Hongxin Dong, Anne M Fagan, et al.
Journal of Neurochemistry|November 5, 2004
A proteasomal stress response: pre-treatment with proteasome inhibitors increases proteasome activity and reduces neuronal vulnerability to oxidative injuryChul-Sang Lee, Lee Y Tee, Timothy Warmke, et al.
Neuropsychology|November 11, 2009
The utility of intraindividual variability in selective attention tasks as an early marker for Alzheimer's diseaseJanet M Duchek, David A Balota, Chi-Shing Tse, et al.
Annals of Neurology|March 5, 2009
Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderlyAnne M Fagan, Denise Head, Aarti R Shah, et al.
Alzheimer Disease and Associated Disorders|June 11, 2020
Physical Exercise and Longitudinal Trajectories in Alzheimer Disease Biomarkers and Cognitive FunctioningMarta Stojanovic, Yuxuan Jin, Anne M Fagan, et al.
Alzheimer'S Research & Therapy|June 15, 2021
GPS driving: a digital biomarker for preclinical Alzheimer diseaseSayeh Bayat, Ganesh M Babulal, Suzanne E Schindler, et al.
Journal of the International Neuropsychological Society : JINS|September 30, 2015
Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children StudyAndrew J Aschenbrenner, David A Balota, Anne M Fagan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 28, 2018
Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's diseaseCourtney L Sutphen, Lena McCue, Elizabeth M Herries, et al.
Journal of the International Neuropsychological Society : JINS|December 12, 2019
The Relation Between Personality and Biomarkers in Sensitivity and Conversion to Alzheimer-Type DementiaJanet M Duchek, Andrew J Aschenbrenner, Anne M Fagan, et al.
Biological Psychiatry|November 7, 2009
Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's diseaseAnthony L Hinrichs, Mark A Mintun, Denise Head, et al.
Pageof 28